Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone helps regrow hair in women with hair loss.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Menopause affects hair and skin; more research needed for treatment.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.